Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer

Clinical trial NCT03043313 · COMPLETED

Trial details

NCT number: NCT03043313
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Adenocarcinoma

Start date: 2017-06-23
Primary completion: 2022-03-28
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.